Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.12 Million CAD | 8.49% |
| 2022 | -15.43 Million CAD | 35.15% |
| 2021 | -23.8 Million CAD | 9.33% |
| 2020 | -26.24 Million CAD | 58.44% |
| 2019 | -63.16 Million CAD | -172.01% |
| 2018 | -23.22 Million CAD | -33.79% |
| 2017 | -17.35 Million CAD | -800.38% |
| 2016 | -1.92 Million CAD | -642.68% |
| 2015 | 355.23 Thousand CAD | 128.39% |
| 2014 | -1.25 Million CAD | -297.49% |
| 2013 | -314.81 Thousand CAD | 34.19% |
| 2012 | -478.38 Thousand CAD | 78.39% |
| 2011 | -2.21 Million CAD | -393.35% |
| 2010 | -448.62 Thousand CAD | -261.88% |
| 2009 | -123.97 Thousand CAD | -295.1% |
| 2008 | -31.37 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.5 Million CAD | 60.08% |
| 2024 Q3 | -1.39 Million CAD | 0.7% |
| 2024 Q2 | -1.4 Million CAD | 44.0% |
| 2023 Q3 | -2.36 Million CAD | -8.2% |
| 2023 Q2 | -2.18 Million CAD | 33.71% |
| 2023 Q1 | -3.3 Million CAD | 59.43% |
| 2023 FY | -14.12 Million CAD | 8.49% |
| 2023 Q4 | -6.26 Million CAD | -164.31% |
| 2022 Q4 | -8.14 Million CAD | -318.88% |
| 2022 Q2 | -3.94 Million CAD | 13.73% |
| 2022 Q1 | -4.57 Million CAD | -14.39% |
| 2022 FY | -15.43 Million CAD | 35.15% |
| 2022 Q3 | -1.94 Million CAD | 50.71% |
| 2021 Q4 | -3.99 Million CAD | 33.98% |
| 2021 Q2 | -6.36 Million CAD | 13.71% |
| 2021 Q1 | -7.38 Million CAD | -18.19% |
| 2021 FY | -23.8 Million CAD | 9.33% |
| 2021 Q3 | -6.05 Million CAD | 4.96% |
| 2020 Q2 | -4.83 Million CAD | 34.27% |
| 2020 Q1 | -7.35 Million CAD | 75.19% |
| 2020 Q3 | -7.81 Million CAD | -61.81% |
| 2020 Q4 | -6.24 Million CAD | 20.13% |
| 2020 FY | -26.24 Million CAD | 58.44% |
| 2019 Q3 | -14.64 Million CAD | -69.81% |
| 2019 Q1 | -10.26 Million CAD | 21.96% |
| 2019 Q2 | -8.62 Million CAD | 16.03% |
| 2019 Q4 | -29.63 Million CAD | -102.36% |
| 2019 FY | -63.16 Million CAD | -172.01% |
| 2018 Q1 | -3.15 Million CAD | -0.67% |
| 2018 FY | -23.22 Million CAD | -33.79% |
| 2018 Q4 | -13.15 Million CAD | -51.62% |
| 2018 Q3 | -8.67 Million CAD | -7.18% |
| 2018 Q2 | -8.09 Million CAD | -156.35% |
| 2017 Q2 | -4.45 Million CAD | -187.08% |
| 2017 Q1 | -1.55 Million CAD | -73.16% |
| 2017 FY | -17.35 Million CAD | -800.38% |
| 2017 Q4 | -3.13 Million CAD | 72.43% |
| 2017 Q3 | -11.37 Million CAD | -155.16% |
| 2016 Q4 | -897.07 Thousand CAD | 27.02% |
| 2016 Q2 | -363.49 Thousand CAD | -73.58% |
| 2016 FY | -1.92 Million CAD | -642.68% |
| 2016 Q1 | -209.4 Thousand CAD | -254.65% |
| 2016 Q3 | -1.22 Million CAD | -238.17% |
| 2015 FY | 355.23 Thousand CAD | 128.39% |
| 2015 Q4 | -59.04 Thousand CAD | -136.03% |
| 2015 Q3 | -25.01 Thousand CAD | 48.55% |
| 2015 Q2 | -48.62 Thousand CAD | 92.6% |
| 2015 Q1 | -656.61 Thousand CAD | -403.98% |
| 2014 Q4 | -130.28 Thousand CAD | 49.82% |
| 2014 FY | -1.25 Million CAD | -297.49% |
| 2014 Q3 | -259.62 Thousand CAD | -26.76% |
| 2014 Q1 | -151.84 Thousand CAD | -408.26% |
| 2014 Q2 | -204.82 Thousand CAD | -34.89% |
| 2013 Q4 | -29.87 Thousand CAD | 56.3% |
| 2013 FY | -314.81 Thousand CAD | 34.19% |
| 2013 Q1 | -67.35 Thousand CAD | 15.28% |
| 2013 Q2 | -64.72 Thousand CAD | 3.9% |
| 2013 Q3 | -68.36 Thousand CAD | -5.63% |
| 2012 Q4 | -79.5 Thousand CAD | 30.01% |
| 2012 Q1 | -1.66 Million CAD | -780.32% |
| 2012 FY | -478.38 Thousand CAD | 78.39% |
| 2012 Q3 | -113.58 Thousand CAD | 47.88% |
| 2012 Q2 | -217.93 Thousand CAD | 86.88% |
| 2011 Q1 | -235.09 Thousand CAD | -353.1% |
| 2011 Q3 | -226.64 Thousand CAD | -66.46% |
| 2011 FY | -2.21 Million CAD | -393.35% |
| 2011 Q2 | -136.15 Thousand CAD | 42.09% |
| 2011 Q4 | -188.76 Thousand CAD | 16.71% |
| 2010 FY | -448.62 Thousand CAD | -261.88% |
| 2010 Q3 | -92.9 Thousand CAD | -35.17% |
| 2010 Q2 | -68.73 Thousand CAD | -63.8% |
| 2010 Q1 | -41.96 Thousand CAD | -374.63% |
| 2010 Q4 | -51.88 Thousand CAD | 44.15% |
| 2009 FY | -123.97 Thousand CAD | -295.1% |
| 2009 Q3 | -45.67 Thousand CAD | -66.12% |
| 2009 Q4 | -8841.00 CAD | 80.64% |
| 2009 Q2 | -27.49 Thousand CAD | 84.0% |
| 2009 Q1 | -171.86 Thousand CAD | -171.35% |
| 2008 FY | -31.37 Thousand CAD | 0.0% |
| 2008 Q4 | 240.87 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | -376.459% |
| CanadaBis Capital Inc. | 4.44 Million CAD | 417.824% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | -698.06% |
| Delivra Health Brands Inc. | 876 Thousand CAD | 1712.519% |
| Entourage Health Corp. | -46.16 Million CAD | 69.404% |
| Cannara Biotech Inc. | 6.94 Million CAD | 303.381% |
| Medicure Inc. | -922 Thousand CAD | -1432.068% |
| PharmaCielo Ltd. | -16.29 Million CAD | 13.327% |
| Rubicon Organics Inc. | -1.82 Million CAD | -674.631% |
| BioSyent Inc. | 6.46 Million CAD | 318.659% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | -909.359% |